Clinical trial

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™…

NCT02439775 · Medtronic Vascular, Industry · Completed

Key facts

NCT number NCT02439775
Title SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
Official title Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Lead sponsor Medtronic Vascular, Industry
Status Completed
Study type Interventional
Conditions Hypertension, Vascular Diseases, Cardiovascular Diseases
Intervention type Device, Procedure
Interventions Symplicity Spyral™ multi-electrode renal denervation system, Sham Procedure
Enrollment 337
Start date Jul 22, 2015
Primary completion Aug 18, 2022
Completion Aug 14, 2025
First posted May 12, 2015
Last update posted Nov 14, 2025
Countries Australia, Austria, Canada, France, Germany, Greece, Ireland, Japan, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies